Trial intelligence / Profile preview

Bone Marrow Cells for Chronic Wounds

NCT02319720Phase 1Terminated

Start
Jul 2008
Primary completion
Mar 2013
Modality
Stem Cell Therapies
01

Overview

Phase 1, randomised, open-label trial of autologous bone marrow aspirate in Chronic wound (4 arms). Primary endpoint: Number of adverse events at 12 months. Started Jul 2008; status: terminated.

02

Drugs

autologous bone marrow aspirate
03

Conditions

Chronic wound

Beyond the preview

Go deeper on NCT02319720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02319720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call